Company Website

Contact Information:

Shane Murray
shmurray@natera.com
904-234-6953

Stephanie Suarez
sllonasuarez@natera.com
813-220-7721

Virtual Exhibit Hall

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.
Signatera™ is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment, treatment response monitoring, and early recurrence monitoring.

Signatera Leadership Brochure